Phibro Animal Health | PAHC - Assets


Phibro Animal Health reported $1.5B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Align Technology USD 6.42B 103.41M Jun/2026
ANI Pharmaceuticals USD 1.49B 72.14M Jun/2026
Aurora Cannabis CAD 601.09M 174.2M Mar/2026
Bristol-Myers Squibb USD 87.63B 1.16B Jun/2026
Canopy Growth CAD 1.12B 12.54M Mar/2026
Corcept Therapeutics USD 888.7M 73.82M Jun/2026
Eli Lilly USD 142.28B 25.71B Jun/2026
Henry Schein USD 11.38B 77M Jun/2026
Idexx Laboratories USD 3.44B 56.84M Jun/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Merck USD 129.8B 1.12B Jun/2026
Nektar Therapeutics USD 763.27M 482.86M Mar/2026
Pacira USD 1.24B 35.44M Jun/2026
Phibro Animal Health USD 1.5B 56.12M Jun/2026
Prestige Brands USD 4.57B 1.07B Jun/2026
Supernus Pharmaceuticals USD 1.43B 72.62M Jun/2026
Zoetis USD 15.08B 77M Jun/2026